Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma

INTRODUCTION: Currently, very few studies are available concerning the mammalian Hippo pathway in bone sarcomas. YAP/TAZ transcription co-activators are key downstream effectors of this pathway and may also have oncogenic properties. Additionally, recent in-vitro experiments showed that expression o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Bouvier, Corinne, Macagno, Nicolas, Nguyen, Quy, Loundou, Anderson, Jiguet-Jiglaire, Carine, Gentet, Jean-Claude, Jouve, Jean-Luc, Rochwerger, Alexandre, Mattei, Jean-Camille, Bouvard, Daniel, Salas, Sébastien
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2016
Materias:
Research Paper: Pathology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5323109/
https://ncbi.nlm.nih.gov/pubmed/27608849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11876
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares